
Your daily dose of clinical news you may have missed.

Metabolomic signatures identified in red and processed meat are associated with an increased risk of IHD, according to new findings.


Migraine disproportionately affects women, a disparity typically ascribed to hormonal differences. A new study takes a new look at the issue.

Among other improvements, bariatric surgery may help reverse peripheral neuropathy and stabilize cardiovascular autonomic neuropathy, according to new findings.

Your daily dose of clinical news you may have missed.

A population-based study found metabolic dysfunction more prevalent than ultrasonographic steatosis in patients recovered from HCV and a better predictive tool for disease progression.

Your daily dose of clinical news you may have missed.

Updated VA/DoD chronic pain management guidelines include recommendations for dual use of buprenorphine and increased mental health assessment before prescribing opioids.

Ensitrelvir fast track status is supported by phase 3 study findings showing resolution of COVID-19 symptoms a full day earlier in those taking the drug vs placebo.

The FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.

Your daily dose of clinical news you may have missed.

Recent research shows that patients with mild-to-moderate COVID-19 who received ensitrelvir within 5 days of symptom onset saw their symptoms resolve a day earlier than those who received placebo.

Pain is a prominent symptom among persons with COPD yet management is not included in clinical guidelines and current research findings are vague, say study authors.

Researchers found sex-specific brain signals that appear to confirm that different drivers lead men and women to develop obesity.

High salt intake linked to coronary atherosclerosis; daily ETOH, even in small doses, is dangerous; statins don't increase muscle injury; and 2 more studies of note.

For each of the 6 biologic agents FDA-approved for severe asthma, find the mechanism of action, indication, and biomarkers that predict enhanced response.

Onset of the 2022-2023 RSV season and its end were closer to historical patterns but atypical circulation may continue, say researchers writing in MMWR.

From type 2 diabetes to migraine, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the first quarter.

Vaccine side effects are usually trouble when they make the news. But sometimes, an unexpected result has merit. Find out more.